[go: up one dir, main page]

FR2872511B1 - Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique - Google Patents

Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique

Info

Publication number
FR2872511B1
FR2872511B1 FR0407235A FR0407235A FR2872511B1 FR 2872511 B1 FR2872511 B1 FR 2872511B1 FR 0407235 A FR0407235 A FR 0407235A FR 0407235 A FR0407235 A FR 0407235A FR 2872511 B1 FR2872511 B1 FR 2872511B1
Authority
FR
France
Prior art keywords
angiogenesis
pharmaceutical
cosmetic use
novel inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0407235A
Other languages
English (en)
Other versions
FR2872511A1 (fr
Inventor
Jacques Eustache
De Weghe Pierre Van
Vincent Rodeschini
Celine Tarnus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Galderma Research and Development SNC
Original Assignee
Centre National de la Recherche Scientifique CNRS
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Galderma Research and Development SNC filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0407235A priority Critical patent/FR2872511B1/fr
Priority to EP05784026A priority patent/EP1763500A1/fr
Priority to PCT/FR2005/001656 priority patent/WO2006010859A1/fr
Priority to CA002570729A priority patent/CA2570729A1/fr
Publication of FR2872511A1 publication Critical patent/FR2872511A1/fr
Application granted granted Critical
Publication of FR2872511B1 publication Critical patent/FR2872511B1/fr
Priority to US11/642,846 priority patent/US7396953B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C21/00—Acyclic unsaturated compounds containing halogen atoms
    • C07C21/02—Acyclic unsaturated compounds containing halogen atoms containing carbon-to-carbon double bonds
    • C07C21/14—Acyclic unsaturated compounds containing halogen atoms containing carbon-to-carbon double bonds containing bromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/02—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0407235A 2004-06-30 2004-06-30 Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique Expired - Fee Related FR2872511B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0407235A FR2872511B1 (fr) 2004-06-30 2004-06-30 Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique
EP05784026A EP1763500A1 (fr) 2004-06-30 2005-06-29 Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique
PCT/FR2005/001656 WO2006010859A1 (fr) 2004-06-30 2005-06-29 Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique
CA002570729A CA2570729A1 (fr) 2004-06-30 2005-06-29 Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique
US11/642,846 US7396953B2 (en) 2004-06-30 2006-12-21 Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0407235A FR2872511B1 (fr) 2004-06-30 2004-06-30 Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique

Publications (2)

Publication Number Publication Date
FR2872511A1 FR2872511A1 (fr) 2006-01-06
FR2872511B1 true FR2872511B1 (fr) 2006-08-11

Family

ID=34953285

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0407235A Expired - Fee Related FR2872511B1 (fr) 2004-06-30 2004-06-30 Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique

Country Status (5)

Country Link
US (1) US7396953B2 (fr)
EP (1) EP1763500A1 (fr)
CA (1) CA2570729A1 (fr)
FR (1) FR2872511B1 (fr)
WO (1) WO2006010859A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070254303A1 (en) * 2006-04-18 2007-11-01 Praecis Pharmaceuticals Incorporated Methods for assessing the efficacy of treatment with a glucocorticoid
CA2706914A1 (fr) * 2007-11-28 2009-06-11 Mersana Therapeutics, Inc. Conjugues d'analogues de fumagilline biocompatibles et biodegradables
AU2009262199B2 (en) 2008-06-27 2012-08-09 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6803382B2 (en) 2001-11-09 2004-10-12 Galderma Research & Development, S.N.C. Angiogenesis inhibitors and pharmaceutical and cosmetic use thereof
FR2832149B1 (fr) * 2001-11-09 2006-01-06 Galderma Res & Dev Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique

Also Published As

Publication number Publication date
FR2872511A1 (fr) 2006-01-06
US7396953B2 (en) 2008-07-08
US20070167519A1 (en) 2007-07-19
CA2570729A1 (fr) 2006-02-02
WO2006010859A1 (fr) 2006-02-02
EP1763500A1 (fr) 2007-03-21

Similar Documents

Publication Publication Date Title
FR2864084B1 (fr) Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
PL377931A1 (pl) Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania
FR2850652B1 (fr) Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
MA28732B1 (fr) Nouveaux derives d'uree cyclique, leur preparation, et leur uttilisation pharmaceutique comme inhibiteurs de la kinase
PL373333A1 (pl) Stosowanie przeciwciał skierowanych przeciw TNFalfa i innego leku
EP1636250A4 (fr) Peptides autoassembles presentant des modifications et methodes d'utilisation des peptides
EP1624935A4 (fr) Composites anti-adherence et methodes d'utilisation desdits composites
EP1796625A4 (fr) Nouvelles formulations de fenofibrate et methodes de traitement s'y relatant
MA28756B1 (fr) Derives substitues d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de la kinase
EP1763490A4 (fr) Appareil d'électrodéionisation et méthodes d'utilisation
MA26882A1 (fr) COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE
DE60225014D1 (de) Pharmazeutische zusammensetzungen von amlodipin und atorvastatin
EP1663255A4 (fr) Compositions de withanamide and withanolide et procede d'utilisation de celles-ci
FR2878439B1 (fr) Nouveaux derives n-acyles d'aminoacides et leur utilisation en cosmetique et en pharmacie
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
EE200100611A (et) NOS inhibiitorite uued farmatseutilised kombinatsioonid
ATE405293T1 (de) Selbstemulgierende und selbstmicroemulgierende formulierungen zur oralen verabreichung von taxoiden
ITMI20041963A1 (it) "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
FR2872511B1 (fr) Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique
FR2868421B1 (fr) Nouveaux benzothiazoles et leur utilisation comme medicaments
EP1757302A4 (fr) Inducteur de l'expression de l'adiponectine et son utilisation
MA27879A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
EP1758577A4 (fr) Nouveaux composes, nouvelles compositions pharmaceutiques contenant ces composes et procedes d'utilisation correspondants
EP1461450A4 (fr) Compositions t-bet et methodes d'utilisation associees
FR2862965B1 (fr) Nouveaux derives de phenoxyacetamides et leur utilisation pour la preparation de diphenylamides.

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20090228